Literature DB >> 8740402

Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer.

A Nakao1, A Harada, T Nonami, T Kaneko, H Takagi.   

Abstract

To elucidate the clinical significance of neural invasion in pancreatic carcinoma, a clinicopathological study was performed. Neural invasion is a common feature of pancreatic carcinoma whose clinical significance has not yet been determined. Over a period of > 10 years, 129 of 204 (63%) patients with pancreatic carcinoma underwent resection by extensive radical surgery. A clinicopathological study of those specimens of pancreatic carcinoma was performed, with particular reference to neural invasion. Intrapancreatic neural invasion was observed in 116 of 129 (90%), of which 80 (69%) showed extrapancreatic nerve plexus involvement. A statistically significant (p < 0.001) correlation between the grade of intrapancreatic neural invasion and extrapancreatic nerve plexus invasion was observed. The postoperative survival rate for patients with extrapancreatic nerve plexus involvement was significantly (p < 0.001) lower than that for patients without extrapancreatic nerve plexus involvement. Patients who survived for > 3 years after operation had no extrapancreatic nerve plexus invasion even when portal vein wall invasion was observed.

Entities:  

Mesh:

Year:  1996        PMID: 8740402     DOI: 10.1097/00006676-199605000-00006

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  62 in total

Review 1.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

Review 2.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Indications and techniques of extended resection for pancreatic cancer.

Authors:  Akimasa Nakao; Shin Takeda; Soichiro Inoue; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Tsutomu Fujii
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

4.  Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study.

Authors:  M Nano; H Dal Corso; M Ferronato; M Solej; J P Hornung
Journal:  Surg Radiol Anat       Date:  2003-02-25       Impact factor: 1.246

5.  Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.

Authors:  Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Fumio Shimamoto; Taijiro Sueda
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

6.  Extended resection for pancreatic adenocarcinoma.

Authors:  T M van Gulik; A Nakao; H Obertop
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

7.  Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

8.  MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy.

Authors:  Kentaro Mochizuki; Toshifumi Gabata; Kazuto Kozaka; Yuki Hattori; Yoh Zen; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Osamu Matsui
Journal:  Eur Radiol       Date:  2010-02-10       Impact factor: 5.315

9.  En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.

Authors:  Hirohisa Kitagawa; Hidehiro Tajima; Hisatoshi Nakagawara; Isamu Makino; Tomoharu Miyashita; Masatoshi Shoji; Shinichi Nakanuma; Norihiro Hayashi; Hiroyuki Takamura; Tetsuo Ohta; Hiroshi Ohtake
Journal:  Mol Clin Oncol       Date:  2014-02-27

10.  Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Samudra Acharya; Hong-Moon Sohn; Jae Yeoul Jun; In-Youb Chang; Ho Jin You
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.